HPV Testing By Self-Collection For Women At High Risk Of Cervical Cancer
Main Category: Cervical Cancer / HPV VaccineAlso Included In: Women's Health / Gynecology
Article Date: 30 Aug 2007 - 5:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
3 (1 votes) |
In this Research letter, Dr. Gina Ogilvie and colleagues investigate the feasibility of self-collection of specimens for HPV testing among women who may not make full use of cytology screening programs (e.g., women who are homeless or who are involved in the sex trade) and are thus at increased risk of cervical cancer. To study the feasibility of self-collected specimens for testing human papillomavirus (HPV) status among hard-to-reach women, outreach nurses recruited women in women's centres, shelters and alleys in Vancouver's Downtown Eastside. Of the 151 participants for whom samples were available, 43 (28.5%) tested positive for high-risk HPV. Outreach nurses were able to recontact 81.4% of the participants who tested positive and referred them for further testing. About 14% (21/151) of participants had never received a Papanicolaou smear in British Columbia, as compared with 8.3% (608/7336) of women in the BC general population (p < 0.05).
The authors' findings suggest that self-collection of specimens is feasible for women who are at high risk of cervical cancer and who do not receive routine cervical cancer screening.
Future studies should include an examination of the rate of follow-up testing among women found to be positive for high-risk HPV. In addition, improved methods are necessary to enhance uptake of follow-up interventions. As well, given the high incidence of this preventable cancer in developing countries, self-collection of specimens for HPV screening could be offered as a component of reproductive health programs and could be administered by health care workers to improve access to cervical cancer screening. Follow-up using screen-and-treat methods could then be used to offer definitive treatment for women at risk for cervical cancer.
###
The paper can be viewed here (PDF).
CMAJ is Canada's leading general medical journal. Published every 2 weeks the journal is mailed to 65,000 subscribers. The full text, open access electronic version http://www.cmaj.ca/ has over 1 million requests per month. The Journal's Impact Factor is 6.9 making it the 6th ranked general medical journal internationally.
Source: Dr. Gina Ogilvie
Canadian Medical Association Journal
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/80783.php>
APA
http://www.medicalnewstoday.com/releases/80783.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




